Plasmodium vivax is the most geographically widespread human malaria parasite. Global
malaria efforts have been less successful at reducing the burden of P. vivax compared to P …

Plasmodium vivax infection, the predominant cause of malaria in Asia and Latin America,
affects~ 14 million individuals annually, with considerable adverse effects on wellbeing and …

A reduction in the global burden of malaria over the past two decades has encouraged
efforts for regional malaria elimination. Despite the need to target all Plasmodium species …

Plasmodium parasite–specific antibodies are critical for protection against malaria, yet the
development of long-lived and effective humoral immunity against Plasmodium takes many …

A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals
carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This …

Malaria elimination means cessation of parasite transmission. At present, the declining
malaria incidence in many countries has made elimination a feasible goal. Transmission …

Plasmodium vivax is responsible for most of the malaria infections outside Africa and is
currently the predominant malaria parasite in countries under elimination programs. P. vivax …

Strengthening malaria surveillance is a key intervention needed to reduce the global
disease burden. Reliable serological markers of recent malaria exposure could improve …

Measurement of malaria specific antibody responses represents a practical and informative
method for malaria control programs to assess recent exposure to infection. Technical …

Plasmodium vivax is the most widespread causative agent of human malaria in the world.
Despite the ongoing implementation of malaria control programs, the rate of case reduction …